Authors: Harris, ST Eriksen, EF Davidson, M Ettinger, MP Moffett, AH Baylink, DJ Crusan, CE Chines, AA

Citation: St. Harris et al., Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women, J CLIN END, 86(5), 2001, pp. 1890-1897

Authors: Miller, PD Woodson, G Licata, AA Ettinger, MP Mako, B Smith, ME Wang, LX Yates, J Melton, ME Palmisano, JJ

Citation: Pd. Miller et al., Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms, CLIN THER, 22(12), 2000, pp. 1433-1442

Authors: Rittmaster, RS Bolognese, M Ettinger, MP Hanley, DA Hodsman, AB Kendler, DL Rosen, CJ

Citation: Rs. Rittmaster et al., Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate, J CLIN END, 85(6), 2000, pp. 2129-2134

Authors: Downs, RW Bell, NH Ettinger, MP Walsh, BW Favus, MJ Mako, B Wang, LX Smith, ME Gormley, GJ Melton, ME

Citation: Rw. Downs et al., Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women, J CLIN END, 85(5), 2000, pp. 1783-1788